Integra LifeSciences | IART - 营业费用



金融业
股票价格
USD
资产
USD 3.58B
现金及等价物
USD 236.81M
销售成本
USD 178.71M
流动资产
USD 1.17B
流动负债
USD 346.85M
债务
USD 2.04B
EBIT
USD 11.47M
EBITDA
USD 76.18M
员工
4.4K
EPS每股收益
USD 0.54
股本和储备
USD 1.04B
销售毛利
USD 213.21M
债务利息支出
USD 22.47M
利息收入
USD 4.11M
贷款资金
USD 1.83B
市值
USD 1.34B
净收入
USD -4.62M
营业费用
USD 1.04B
营业利润
USD 11.47M
普通股股本
USD 77.82M
PE价格收益
5.07
税前利润
USD -2.41M
销售收入
USD 391.9M
销售和管理费用
USD 178.24M
股票
USD 495.04M
贸易债权人
USD 87.95M
应收帐款人
USD 264.41M


营业费用 更改 日
Abbott USD 9.31B 104M 2026-03
AtriCure USD 140.72M 2.71M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
CONMED USD 291.63M 44.94M 2026-03
Cooper Companies USD 1.11B 301.2M 2026-03
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 595.85M 49.26M 2026-03
HeartBeam USD 5.31M 20K 2025-12
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Medtronic USD 7.72B 436M 2026-03
Merit Medical Systems USD 337.72M 2.02M 2026-03
Orthofix International USD 213.79M 12.36M 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03